Insomnia Risk with Cardiovascular Medications

Medication-Related Insomnia Risk

• The American Academy of Sleep Medicine emphasizes that polypharmacy with multiple medications can create additive or synergistic effects contributing to insomnia 1
• Cardiovascular agents, including beta-blockers, alpha-receptor agents, and diuretics, are recognized contributors to insomnia, but ACE inhibitors and calcium channel blockers are generally not considered major culprits 1

Clinical Evaluation and Management

• The American Academy of Sleep Medicine states that fatigue is the expected consequence of insomnia, while true sleepiness suggests alternative sleep disorders like obstructive sleep apnea 1, 2
• The American College of Physicians recommends cognitive behavioral therapy for insomnia as first-line treatment before adding pharmacotherapy, regardless of medication-related contributions 3, 4

Diagnostic Considerations

• Do not confuse fatigue with sleepiness when assessing these patients - fatigue is the predominant complaint in chronic insomnia, whereas involuntary sleep episodes suggest alternative diagnoses 1, 2
• Avoid excessive laboratory testing - insomnia diagnosis is clinical and does not require polysomnography 2